These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31115081)

  • 1. Cross-sectional HIV incidence estimation in an evolving epidemic.
    Morrison D; Laeyendecker O; Brookmeyer R
    Stat Med; 2019 Aug; 38(19):3614-3627. PubMed ID: 31115081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-Sectional HIV Incidence Estimation with Missing Biomarkers.
    Morrison D; Laeyendecker O; Konikoff J; Brookmeyer R
    Stat Commun Infect Dis; 2018 Dec; 10(1):. PubMed ID: 30701015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-sectional HIV incidence estimation in HIV prevention research.
    Brookmeyer R; Laeyendecker O; Donnell D; Eshleman SH
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S233-9. PubMed ID: 23764641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and indirect estimates of HIV-1 incidence in a high-prevalence population.
    Cleghorn FR; Jack N; Murphy JR; Edwards J; Mahabir B; Paul R; O'Brien T; Greenberg M; Weinhold K; Bartholomew C; Brookmeyer R; Blattner WA
    Am J Epidemiol; 1998 May; 147(9):834-9. PubMed ID: 9583713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An enhanced cross-sectional HIV incidence estimator that incorporates prior HIV test results.
    Bannick M; Donnell D; Hayes R; Laeyendecker O; Gao F
    Stat Med; 2024 Jul; 43(17):3125-3139. PubMed ID: 38803064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of HIV incidence using multiple biomarkers.
    Brookmeyer R; Konikoff J; Laeyendecker O; Eshleman SH
    Am J Epidemiol; 2013 Feb; 177(3):264-72. PubMed ID: 23302151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional human immunodeficiency virus incidence estimation accounting for heterogeneity across communities.
    Xu Y; Laeyendecker O; Wang R
    Biometrics; 2019 Sep; 75(3):1017-1028. PubMed ID: 30746695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay.
    McDougal JS; Parekh BS; Peterson ML; Branson BM; Dobbs T; Ackers M; Gurwith M
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):945-52. PubMed ID: 17067263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simpler tool for estimation of HIV incidence from cross-sectional, age-specific prevalence data.
    Rajan SS; Sokal D
    J Epidemiol Community Health; 2011 Feb; 65(2):111-5. PubMed ID: 20558420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size methods for estimating HIV incidence from cross-sectional surveys.
    Konikoff J; Brookmeyer R
    Biometrics; 2015 Dec; 71(4):1121-9. PubMed ID: 26302040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical considerations for cross-sectional HIV incidence estimation based on recency test.
    Gao F; Bannick M
    Stat Med; 2022 Apr; 41(8):1446-1461. PubMed ID: 34984710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should biomarker estimates of HIV incidence be adjusted?
    Brookmeyer R
    AIDS; 2009 Feb; 23(4):485-91. PubMed ID: 19165087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented cross-sectional prevalence testing for estimating HIV incidence.
    Wang R; Lagakos SW
    Biometrics; 2010 Sep; 66(3):864-74. PubMed ID: 19912174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the use of adjusted cross-sectional estimators of HIV incidence.
    Wang R; Lagakos SW
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):538-47. PubMed ID: 19881357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIITE: HIV-1 incidence and infection time estimator.
    Park SY; Love TMT; Kapoor S; Lee HY
    Bioinformatics; 2018 Jun; 34(12):2046-2052. PubMed ID: 29438560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of incidence of HIV infection using cross-sectional marker surveys.
    Statten GA; Longini IM
    Biometrics; 1994 Sep; 50(3):675-88. PubMed ID: 7981394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented cross-sectional studies with abbreviated follow-up for estimating HIV incidence.
    Claggett B; Lagakos SW; Wang R
    Biometrics; 2012 Mar; 68(1):62-74. PubMed ID: 21668904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the Limiting Antigen Avidity Assay to Estimate Level and Trends in HIV Incidence in an A/D Epidemic in Rakai, Uganda.
    Laeyendecker O; Gray RH; Grabowski MK; Reynolds SJ; Ndyanabo A; Ssekasanvu J; Fernandez RE; Wawer MJ; Serwadda D; Quinn TC
    AIDS Res Hum Retroviruses; 2019 Apr; 35(4):364-367. PubMed ID: 30560723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method for estimating HIV incidence from a single cross-sectional survey.
    Fellows IE; Shiraishi RW; Cherutich P; Achia T; Young PW; Kim AA
    PLoS One; 2020; 15(8):e0237221. PubMed ID: 32785257
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.